Literature DB >> 12520248

Differences in resting energy expenditure between male and female children with cystic fibrosis.

Jane R Allen1, James C McCauley, Andrew M Selby, Donna L Waters, Margie A Gruca, Louise A Baur, Peter Van Asperen, Kevin J Gaskin.   

Abstract

OBJECTIVES: To evaluate which factors might contribute to raised resting energy expenditure (REE) in patients with cystic fibrosis (CF). STUDY
DESIGN: REE and anthropometry were measured in 134 (males = 68) children with CF and 100 (males = 51) controls (range, 3-18.7 years) in an outpatient setting. Bacterial colonization, liver disease, inhaled steroid use, pancreatic and pulmonary function, sex, and genotype were determined and regression analysis was used to determine the predictors of REE in the group with CF.
RESULTS: REE for children with CF was increased on average by 7.2% compared with controls. This increase was greater for females than for males. REE in males was positively associated with fat-free mass (FFM), pancreatic insufficiency (PI), and liver disease, and negatively associated with pulmonary function, whereas in females, REE was positively associated with FFM and PI. REE (adjusted for FFM) was higher in children with a severe mutation (5495 +/- 47 kJ) compared with a mild mutation (5,176 +/- 124 kJ, P <.02).
CONCLUSIONS: PI, severe mutations, and female sex are the main contributing factors to elevated REE in patients with CF with near normal pulmonary function.

Entities:  

Mesh:

Year:  2003        PMID: 12520248     DOI: 10.1067/mpd.2003.mpd0338

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  2 in total

1.  Effect of a dietary intervention on growth and energy expenditure in children with cystic fibrosis.

Authors:  Veronique Groleau; Joan I Schall; Kelly A Dougherty; Norma E Latham; Asim Maqbool; Maria R Mascarenhas; Virginia A Stallings
Journal:  J Cyst Fibros       Date:  2014-02-08       Impact factor: 5.482

2.  Genetic influences on cystic fibrosis lung disease severity.

Authors:  Colleen A Weiler; Mitchell L Drumm
Journal:  Front Pharmacol       Date:  2013-04-23       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.